SCHRöDINGER
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 700 employees and is engaged with customers and collaborators in more than 70 countries. To learn more visit www.schrodinger.com.
SCHRöDINGER
Industry:
Biotechnology Enterprise Software Pharmaceutical Software
Founded:
1990-08-16
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.schrodinger.com
Total Employee:
501+
Status:
Active
Contact:
1 503 299 1150
Email Addresses:
[email protected]
Total Funding:
567.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Dls Solutions Inc
DLS Solutions develops custom software for analytical and biotechnology instrumentation.
MolecularWare
MolecularWare develops data management software for high throughput biology.
Reify
Reify develops and markets machine vision and video analysis software-based phenotypic screens for the biotechnology industries.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-01-18 | Xtal BioStructures | Xtal BioStructures acquired by Schrödinger | 6 M USD |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Schrödinger
Pavilion Capital
Pavilion Capital investment in Series E - Schrödinger
Michael Antonov
Michael Antonov investment in Series E - Schrödinger
Invus
Invus investment in Series E - Schrödinger
Laurion Capital Management
Laurion Capital Management investment in Series E - Schrödinger
Sixty Degree Capital
Sixty Degree Capital investment in Series E - Schrödinger
Formic Ventures
Formic Ventures investment in Venture Round - Schrödinger
GV
GV investment in Series E - Schrödinger
WuXi AppTec
WuXi AppTec investment in Series E - Schrödinger
Deerfield
Deerfield investment in Series E - Schrödinger
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-10-20 | ShouTi | Schrödinger investment in Series B - ShouTi | 100 M USD |
2021-06-01 | Ajax Therapeutics | Schrödinger investment in Venture Round - Ajax Therapeutics | 40 M USD |
2019-12-03 | Bright Angel Therapeutics | Schrödinger investment in Seed Round - Bright Angel Therapeutics | N/A |
2018-09-25 | Morphic Therapeutic | Schrödinger investment in Series B - Morphic Therapeutic | 80 M USD |
2018-06-05 | Nimbus Therapeutics | Schrödinger investment in Series C - Nimbus Therapeutics | 65 M USD |
2016-06-30 | Morphic Therapeutic | Schrödinger investment in Series A - Morphic Therapeutic | 51.5 M USD |
2016-01-01 | Morphic Therapeutic | Schrödinger investment in Seed Round - Morphic Therapeutic | 3 M USD |
2010-04-29 | Nimbus Therapeutics | Schrödinger investment in Seed Round - Nimbus Therapeutics | 3.5 M USD |
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-08-18 | Schrödinger Appoints Geoffrey Porges as Chief Financial Officer |
Official Site Inspections
http://www.schrodinger.com Semrush global rank: 338.39 K Semrush visits lastest month: 178.24 K
- Host name: 192.0.66.218
- IP address: 192.0.66.218
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110